The excitement over a novel class of drugs being developed to fight HIV has been dampened by fears they could pose serious safety risks, including the possibility they might actually speed the progression of AIDS.
The excitement over a novel class of drugs being developed to fight HIV has been dampened by fears they could pose serious safety risks, including the possibility they might actually speed the progression of AIDS.
